Fingerprint
Dive into the research topics of 'Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
EMBRACE
- Harvard T.H. Chan School of Public Health
- The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan 52621, and the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- University of Chicago
- The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China.
- Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
- INBIOMED, Faculty of Medicine/CONICET and CEMIC, Department of Clinical Chemistry, Medical Direction, University of Buenos Aires, Buenos Aires, Argentina.
- Sime Darby Medical Centre
- Odense University Hospital
- Division of Clinical Cancer Genomics, City of Hope Cancer Center, California, USA.
- Division of Molecular Pathology, Department of Pathology, Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong.
- Mayo Clinic
- University of Utah
- Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.
- Seoul National University
- Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
- Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, South Africa.
- University of Cambridge
- Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia. [email protected].
- Leiden University
- City of Hope Clinical Cancer Genomics Community Research Network, Duarte, USA.
- Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV), IRCCS, Padua, Italy.
- Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
- Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, Australia.
- Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
- Laboratory of Cell Biology, Department of Pathology, hus 9, Landspitali-LSH v/Hringbraut, 101 Reykjavik, Iceland and BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- Department of Gynaecology & Oncology, Medical University of Vienna, Austria.
- MD Anderson Cancer Center
- Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.
- Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Instituto Nazionale Tumori (INT), Milan, Italy.
- Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Vall d'Hebron, 08035, Barcelona, Spain.
- European Institute of Oncology
- Human Genetics Group, Spanish National Cancer Centre (CNIO) and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
- Sheba Medical Center
- UCSF Cancer Genetics and Prevention Program, San Francisco, USA.
- Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
- Centre Léon Bérard
Research output: Contribution to journal › Article › peer-review
229
Citations
(Scopus)